Skip to content

Clinical trials

Thyroid Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Neoplasms Country / region: South Korea Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20081
20096
20104
20114
20121
20135
20142
20153
20164
20176
20184
20193
20203
20212
20221
20234
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Unknown status13
Active, not recruiting7
Recruiting3
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yonsei University11
Seoul National University Hospital6
National Cancer Center, Korea4
Samsung Medical Center4
Eli Lilly and Company3
Exelixis3
Inha University Hospital3
Bayer2
Eisai Inc.2
Ilsan Cha hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Neoplasms58
Carcinoma, Medullary8
Carcinoma, Non-Small-Cell Lung8
Thyroid Cancer, Papillary7
Breast Neoplasms6
Colonic Neoplasms6
Head and Neck Neoplasms6
Thyroid Diseases6
Lung Neoplasms5
Neoplasms5

Trials

Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.